The mouse model has been used previously for the study of protection against challenge with strains of group B Streptococcus types Ia, Ib, and Ic, but investigators have not yet been successful in causing lethal disease when type III strains are inoculated. In this study, six clinical isolates belonging to serotype III were lethal in seven-weekold outbred albino mice; the 50% lethal dose (LD 50) for mice tested ranged from 1.8 X 10 4 to 4.6 X 10 6 . In contrast, a laboratory prototype strain of serotyype III was not lethal. The lethality observed with this protection test depended on both the volume of the inoculum given and the medium in which the streptococci were suspended. LD 50 values decreased as the volume of the inoculum, given intraperitoneally, increased, up to a volume of 1.5 ml. Hyperimmune rabbit antiserum to a clinical isolate of type III protected mice against an estimated 90% lethal dose of the isolate. Normal rabbit serum and heterologous antisera, except for one of two antisera to type Ia organisms, were not protective. Absorption of type III antiserum with whole organisms of serotype III or with purified, type III-specific polysaccharide inhibited protection of mice against type III organisms.
During the 1970s, there has been a widely recognized increase in neonatal infections due to group B Streptococcus. Concomitantly, research efforts have been directed toward study of both the nature of streptococci and the disease process that they cause. Studies of immunity have utilized functional assays that include in vitro opsonization [1] [2] [3] [4] [5] , mouse protection tests [3, 6] , and a chick embryo model [7] . The mouse model has been useful for the study of protection against strains of group B Streptococcus types Ia, Ib, and Ic with antigens from strains of these serotypes [6] , but such studies have not dealt with strains of serotype III, due to lack of success in causing lethal disease in mice when type III strains are inoculated [3, 7, 8] .
Type III strains have been recognized as being responsible for a major portion of all neonatal disease due to group B streptococci and virtually all meningitis due to these organisms [9, 10] . Neonatal susceptibility has been associated with antibody deficiencies by means of an opsonic test [2] and a radioactive antigen-binding assay measuring antibody to the native type III polysaccharide antigen [11] . Because of the importance of this serotype of group B Streptococcus, an animal protection test for study of the antigenic specificity and function of antibodies in group B streptococcal infections due to serotype III has been developed and is reported herein.
Materials and Methods
Strains of bacteria. Prototype strains of group B St1"eptococcus-090 (serotype Ia), H36B (Ib), A909 (Ie), 18RS21 (II), and D136C (III)-were supplied by Dr. Rebecca Lancefield, The Rockefeller University, New York, N.V. Clinical isolates of type III-M732, M734, and~M735 (meningeal isolates) and PGF3035 and PGF3038 (vaginal isolates from pregnant women in their third trimester)-were supplied by Dr. Carol J.
Baker, Baylor College of Medicine, Houston, Tex. All strains were stored at -70 C in I.O-ml aliquots in Todd-Hewitt broth (Difco Laboratories, Detroit, Mich.). In mouse protection tests, isolate M732 was used as the challenge organism. After 12 passages in mice, log-phase, broth-grown organisms were frozen and stored at -70 C. Aliquots from one flask of isolate lVI732 were used for all experiments described in this report.
Passage of group B streptococci in mice. In an attempt to enhance virulence, several strains of group B Streptococcus were passaged serially in six-week-old male CD-I albino mice weighing --26 g (Charles River Breeding Laboratories, Wilmington, Mass.) by ip infection and isolation from spleen according to the method of Lancefield et al. [6] . Strain 090 (serotype la) and isolate M732 (III) were passaged by serial ip implantation of I ml of spleen homogenate from infected mice. Strain D 136C was less virulent; in general, mice did not die from infection and their spleens had few viable bacteria. This strain had to be subcultured on blood agar between passages 10 mice.
Preparation of antisera. Male New Zealand white rabbits weighing --4 lb (Plummer's Rabbitry, Grafton, Vt.) were immunized with formalinized, whole-cell vaccines of strains of group B Streptococcus according to the method of Lancefield et al. [6] for preparation of type-specific antisera. The antisera was frozen and stored at -70 C in aliquots (1-2 ml) without preservatives. Each aliquot was thawed immediately before use in opsonophagocytic or mouse protection tests.
A bsorption of antisera from immunized rabbits with whole bacterial cells. Antiserum to isolate M732 was diluted I: 100 in saline. The surface growth from one agar plate confluently streaked with group B streptococci was added to 3-ml aliquots of diluted antiserum. The Lancefield prototype strains were used except in the case of serotype III, in which isolate M732 was substituted. The mixture was cooled on ice and mixed every 10 min for 1 hr with a Vortex Junior mixer (Scientific Industries, Bohemia, N.Y.). The antisera were centrifuged at 12,000 g for 2 min in a Brinkmann Eppendorf model no. 3200 centrifuge (Brinkmann Instruments, Westbury, N.Y.), and the supernatant was sterilized by filtration through a Milf ipore filter with 0.45-fLm pores (Millipore Corp., Bedford, Mass.),
A bsorption with soluble, type-specific polysaccharide. To 2 ml of a 1:100 dilution of type III-specific antiserum was added 1 mg of the native type III polysaccharide [12] . This mixture was incubated at 37 C for 2 hr and then overnight at 4 C. The absorption was repeated on the following day. An identical double absorption of type III antiserum was performed with the native type Ia polysaccharide. Details of the preparation and characteristics of this antigen are the subject of a manuscript in preparation (D.L.K.).
Mouse lethality tests. Strains of group B Streptococcus were tested for virulence in mice by a method similar to that described by Lancefield et al. [6] . Strains to be tested were grown for 16 hr in blood broth containing 5% bovine blood in heart infusion broth. The overnight culture was started with 0.1 ml of log phase-growing streptococci with an OD of 1.0 (measured at 650 nm) in 100 ml of blood broth. The incubated blood broth culture contained --2.5 Mouse protection tests. For tests of mouse protection, both bacteria and antisera were put into the same syringe. The mixture contained a dose of bacteria estimated by the method of Reed and Muench [13] to kill 90% of mice tested (LD 90) in 0.6 ml of blood broth. To this preparation were added 0.2 ml of antiserum of the appropriate dilution (in normal saline) and 0.4 ml of blood broth. Thus, there was 1.0 ml of blood broth in this total volume of 1.2 ml, as in the tests of lethality for mice. For studies of inhibition of protection, the contents of the syringe were the same except that 0.2 ml of absorbed antiserum was substituted for the antiserum. Dead mice were counted and removed from their cages at 24-hr intervals.
Opsonophagocytic test. Mouse lethality tests. Preliminary experiments showed that five of the six strains of group B Streptococcus type III studied caused the death of sufficient numbers of infected mice for determination of an LD 50 value. Only strain D136C, the prototype laboratory strain, did not cause death regularly. The effects of two parameters on lethality were studied: the volume of the inoculum given and the diluent used (table 1) . Isolate M732 (serotype III) was equally virulent whether diluted in blood broth or in ToddHewitt broth, but lethality was dependent on the volume of the inoculum given. When an LD90 (calculated for a volume of l.0 ml of blood broth) was contained in a volume of 0.2 ml of either type of broth, there were no deaths, whereas, when the volume of either broth was l.0 ml, seven of eight mice died. An intermediate volume of broth (0.5 ml) gave intermediate mortalities. When overnight cultures of isolate 1\'1732 were diluted in saline, however, the same number of organisms was not lethal in any of the volumes tested (table 1) . When the inoculum volume was increased to 1.5 ml in blood broth, the LD 5 0 was reduced to 8.6 X 10 4 , but a further increase in volume to 2.0 ml did not result in a further decrease in LD50' It does not appear that the virulence factor is the red blood cells because virulence of isolate 1\1732 was the same in Todd-Hewitt broth as in blood broth. When 10% blood broth was used as the diluent, the mortality did not change; with an LD 90 in a volume of 1.0 ml, seven of eight mice died. With a volume of 0.5 ml, four of eight mice died, and with 0.2 ml, none of eight mice died. One milliliter of the sterile supernatant of an overnight culture to which fresh red blood cells were added was not lethal to any of eight mice injected. For lethality and protection experiments, a volume of 1.0 ml of streptococci in blood broth was chosen. This volume gave consistent results and allowed additional serum to be added when sera were tested for protection.
The need for a broth diluent to maintain virulence appears to be considerably more important for group B Streptococcus type III than for type Ia. When overnight cultures of type la organisms were diluted to 10-8 , a l.O-ml inoculum was lethal to four of six mice inoculated with type Ia organisms diluted in saline. Three of six mice died after inoculation of type Ia organisms diluted in blood broth. In this experiment, duplicate l.O-ml inocula of each of the two diluents at 10-8 , plated at the same time on blood agar, grew two colonies. tibody-free complement, and specific antiserum are mixed by end-over-end rotation, was used. A >90% reduction in numbers of c£u in 1 hr was considered significant opsonization. The titer of serum was defined as the highest dilution of antiserum that caused >90% reduction in numbers of c£u in 1 hr.
Statistical analysis. LD 50 values were calculated by the method of Reed and Muench [13] , with eight or 10 mice used for each dilution of the streptococcal culture. Comparison of significance of differences between mortality values in absorption tests was performed by use of the exact test for 2 X 2 tables [14] . late M732 was the most virulent. The two vaginal isolates, PGF3035 and PGF3038, were the most virulent of the type III strains tested and were passaged fewer times on agar plates after initial isolation than were the other strains.
NOTE. See Materials and Methods for culture and injection procedures.
*This strain was passaged serially 12 times in mice before testing. The mean number (± SD) of efu in three challenge tests with l O-fold dilutions of this strain was 3.90 ± 1.8 X 105 efu (range, 1.85-5.14 X lOS cfu).
tTwo of eight mice given undiluted broth culture containing 3.5 X 10 7 efu died. None of eight mice given diluted broth culture died.
:tThis strain was passaged serially 14 times in mice before testing. All of six mice given 1 ml of a 10-8 dilution of a culture of 3.6 X 10 8 efu/ml died.
D 136C, a reference strain, had been passaged on agar plates innumerable times. Before being tested, it had been passaged seven times in mice.
Protection tests with hyperimmune rabbit antisera. Protection tests were performed with suspensions of bacteria and antisera diluted in 1.0 ml of blood broth injected simultaneously into mice. End points of protection were determined by dilution of the antiserum and use of eight mice for each dilution, as shown in figure 1. Against an LD 90 of isolate M732, type III-specific antiserum from immunized rabbits was >50c.7o protective at a dilution of I: 1,000. Antiserum from another rabbit immunized in a similar manner was protective at a dilution of I: 10 but not at a dilution of I: 100. Undiluted serum from an unimmunized rabbit was not protective; seven of eight mice inoculated with this serum died.
The results of another protection test, in which homologous and heterologous antisera were used, are shown in table 3. In this experiment, undiluted antiserum was used for protection. The type III antiserum was protective, and all eight mice that were challenged survived. Normal rabbit serum and antisera to types Ib, Ie, and II were not protective, and the survival rate was not significantly increased over that in the control group given saline instead of antiserum (P 3.9 X lOs* >3.5 X 10 7 t 4.55 X 10 6 3.1 X 10 6 1. ..
10-2 10°,10. 1 Figure 1 . Cumulative number of deaths among groups of eight mice inoculated simultaneously with a dose of group B Streptococcus type III estimated by the method of Reed and Muench [13] to be lethal to 90% of mice tested (3.6 x 10 6 cfu of meningeal isolate M732, contained in 1.0 ml of blood broth) and with antiserum to isolate M732 (from immunized rabbits) of the indicated dil- NOTE. The number of streptococci in each inoculum was 3.6 X 10 6 cfu; this dose was estimated by the method of Reed and Muench [13] to be lethal to 90% of mice tested when the diluent volume was 1.0 ml of blood broth. In this test, undiluted serum was used for protection of mice. See Materials and Methods for the procedures used for preparation of antisera and injection of mice.
*Deaths counted 72 hr after injection. tAntiserum to the type Ia strain with an opsonic titer of 1: 1,000 against the type Ia strain but not opsonic against the type III strain (no reduction in numbers of cfu at titers of~1 :5).
iAntiserum to the type Ia strain with an opsonic titer of 1: 100 against both the type Ia strain and the type III strain. 0.39 by the exact test for each serum). We determined that each of these sera contained antibody to the homologous strain by the opsonic assay, in which the opsonic titers were as follows: type Ib, 1: 10,000; Ic, 1: 1,000; II, 1: 1,000; and III, I: 100. Two sources of antiserum to type la were tested. One antiserum, designated la (A) in table 3, had an opsonic titer of 1: 1,000 against the type la strain but was not opsonic against the type III strain (no reduction in numbers of C£u at titers of~l :5). The other antiserum, designated la (B) in table 3 and obtained from another rabbit immunized concurrently, had an opsonic titer of 1: 100 against both the type Ia strain and the type III strain. Antiserum la (A) was not protective in the mouse protection test (seven of eight mice died), whereas antiserum Ib (B) was protective (none of eight mice died).
Inhibition of protection by absorption ot antisera with whole bacterial cells. To study the specificity of the mouse protection test, we performed inhibition studies with whole organisms (table 4 ). An LD!l(l of the challenge organism, isolate M732 (type III), killed all of 10 mice not given protective antiserum. When unabsorbed No. deadl no. tested* Serotype used for absorption protective antiserum was given simultaneously with an LD gO of isolate M732, all of the 10 mice in that group survived. Prior absorption of the antiserum with isolate M732, the homologous strain, resulted in the loss of all protective capacity, and all of 10 mice died. Some of the protective ability of this antiserum was lost when the antiserum was absorbed with organisms of type la or Ib (eight of 10 and six of 10 mice died, respectively). According to the exact test for comparison of the results for absorbed antisera with those for unabsorbed antisera, antiserum previously absorbed with whole bacteria of type Ia, Ib, or III gave significantly less protection than did unabsorbed antiserum (P < 0.05).
Absorption of the type III-specific antiserum with organisms of type Ic or type II did not significantly alter the protection rate.
Inhibition o] protection by absorption with soluble, type-specific polysaccharide antigens.
Type III-specific polysaccharide antigen was preincubated with antiserum diluted 1:100. This absorbed antiserum, as well as an unabsorbed control antiserum handled identically, was used in the test of protection against challenge with isolate M732. Another aliquot of type III-specific antiserum was absorbed with type Ia-specific polysaccharide. The unabsorbed antiserum protected eight of 10 mice in this test, and, in Table 5 . Inhibition of the protective effect of antiserum from immunized rabbits on challenge of mice with group B Streptococcus type III by absorption of serum with soluble, type-specific streptococcal polysaccharide.
NOTE. The number of streptococci in each inoculum was 3 X 10 6 cfu of meningeal isolate M732, diluted 1: 100. This dose was estimated by the method of Reed and Muench [13] to be lethal to 90% of mice tested when the diluent volume was 1.0 ml of blood broth. See Materials and Methods for the procedures used for preparation and absorption of antisera and injection of mice.
*Deaths counted 72 hr after injection. tSaline used in place of antiserum.
The mouse lethality model, which was helpful to Lancefield et al. [6] for the elucidation of the antigenic specificity of protective antibodies to serotypes la, Ib, and Ic and which was used by Stewardson-Krieger et al. [3] for the study of perinatal immunity, has never been successfully adapted for type III strains. It has been shown that type III strains are of predominant importance in human neonatal disease caused by group B Streptococcus, especially in meningitis and all late-onset disease [10, 11] . Although it has been maintained by several investigators that type III strains are not virulent in mice [7, 8] , we have shown that, under defined conditions, most type III strains are virulent in mice and that protection can be studied. The sensitivity of the assay is dependent on the volume of the inoculum given and the diluent, and dilution of the organism in 1.0 ml of blood broth provides a reproducible test. We also found that recent isolates of type III strains were virulent, although the LD 50 varied between strains from 1.8 X 10 4 to 4.55 X 10 6 cfu, and that D136C, a strain used by many investigators, was not virulent enough for determination of an LD 50. Serum from a rabbit immunized with isolate NI732 (type III) was highly protective against challenge with that strain. Absorption of this antiserum with an EDTA-extracted, soluble, type III polysaccharide antigen inhibited the protection afforded by the the group given no antiserum, all of 10 mice died (table 5) . Absorption with type III polysaccharide resulted in the loss of most of the protective ability of the antiserum, with six of 10 mice dying, while absorption with type la polysaccharide did not result in such a loss, so that all of 10 mice survived. Absorption with the type III-specific antigen resulted in the loss of a significant amount of protection from this antiserum (P = 0.002), whereas absorption with type la polysaccharide failed to destroy the protective ability of the type III antiserum.
Effect of serial passages in mice on opsonizetion and correlation of mouse protection and opsonic titers.
Isolate M732 (type III) was passaged 12 times in mice, and strain 090 (type Ia), 14 times. When strain D 136C (type III) was passaged in mice, the spleens of the mice were sterile on the second passage. Thus, after every passage in mice, the organism was reisolated and grown in blood broth and then reinoculated into another mouse. By this method, there were seven passages in 14 mice.
Opsonic tests were performed with use of homologous antiserum for opsonization of each strain. Two samples of each strain were tested simultaneously: one that had not been passaged serially in mice and one that had. In each case, the opsonic titer of the antiserum did not change: for isolate M732 (type III) it was 1:1,600, and for strain 090 (type Ia) it was 1: 1,000. Strain DI36C (type III) was killed with polymorphonuclear leukocytes alone, without antiserum, and serial passage in mice did not change this unique property, which had been reported pre-
The same three strains (M732, 090, and D 136C) were tested for lethality in mice before and after serial passage in mice; lethality was the same before and after serial passage for each strain.
Discussion
Functional assays of immunity are important for the study of natural immunity and protection from infections. For type III strains of group B Streptococcus, studies have been performed that utilize in vitro opsonization [1-5], a chick embryo model [7] , and tests of lethality in rats [15] . These results are similar to those of previous studies we have performed with isolate 1\1732 using the opsonophagocytic assay, in which homologous type III antiserum from immunized rabbits and type Ia antiserum were opsonic but other heterologous type-specific antisera were not. In the opsonophagocytic assay, the homologous antiserum could be inhibited by absorption with the same type III-specific polysaccharide antigen that removed the protective capacity of the type III antiserum studied here [1] . No test of inhibition of type III antiserum with whole streptococci was performed in the opsonophagocytic study. In this investigation, absorption with organisms of the type Ia strain inhibited most of the protective ability of the type III antiserum. However, absorption with the type Ia polysaccharide failed to remove the protective antibody from the type III antiserum. This observation indicates that an antigenic determinant other than the type la-specific polysaccharide is shared by strains of serotype Ia and III and that antibody to this determinant has protective capacity. There is other evidence for immunologic crossreactivity between these two serotypes. In the opsonophagocytic study, unabsorbed antiserum to type Ia streptococci opsonized type III organisms [I] . In the study reported herein, a type Ia antiserum that had opsonic antibody was protective, but another type Ia antiserum without opsonins was not protective. Thus, it appears that the same array of antibodies is not present in different type Ia antisera. In the chick embryo studies of Tieffenberg et al. [7] , type Ia antiserum had only slight protective activity against challenge with a type III strain, and absorption with type Ia or type III organisms inhibited this activity.
Opsonophagocytic assays are assumed to have relevance in indicating functional protection from infection in an in vitro system. StewardsonKrieger et al. [3] reported a correlation between opsonization and protection of mice for group B Streptococcus type la in tests of human sera. Our studies with rabbit sera suggest that the same is true for type III organisms. Rabbit sera were tested in both the opsonic and the mouse pro-87 tection assays and were shown to have similar protective properties. Nonimmune rabbit serum and heterologous antisera to types Ib, Ie, and II were not protective in either of the assays. Similar studies have not yet been performed with human sera. Finally, absorption of antisera with type III-specific polysaccharide inhibits both of the assays. Human antibody to this antigen correlates with transplacental protection against neonatal disease caused by group B Streptococcus type III [II] , and antibody to this antigen in rabbit serum appears to protect mice against challenge with a strain of group B Streptococcus type III.
